Brightspring Health Services

BTSG · NASDAQ

$62.42+$1.13 (+1.84%)TodayMarket closed ·
Prev close $61.29

About BTSG

BrightSpring Health Services, Inc. engages in the provision of a platform of complementary health services delivering and pharmacy solutions for complex populations in home and community settings. The company is headquartered in Louisville, Kentucky and currently employs 23,500 full-time employees. The company went IPO on 2024-01-26. Through the Company’s service lines, including pharmacy, home health care and rehabilitation, it provides comprehensive and more integrated care and clinical solutions in all 50 states to customers, clients and patients. Its services are organized and managed through two reportable segments: Pharmacy Solutions and Provider Services. Pharmacy Solutions segment operates long-term institutional pharmacies, hospice pharmacies, specialty oncology pharmacies, and home infusion centers. The company provides infused, injectable, and oral medication services in the home and clinic. Provider Services segment provides a variety of services to help manage the whole-person health of its patients in their homes and communities through services such as home health care and hospice care and long-term specialty care.

Employees
23,500
Headquarters
Louisville, Kentucky
Listed
Jan 26, 2024
Sector
Health Care
Industry
Health Care Providers & Services

BTSG key statistics

Market cap
12.13B
Price-earnings ratio
36.92
Dividend yield
—
Average volume
2.12M
Volume
1.11M
Open price
$61.29
High today
$62.97
Low today
$61.29
52 Week high
$73.75
52 Week low
$29.01

Brightspring Health Services (BTSG) at a glance

As of Oct 20, 2026, Brightspring Health Services (BTSG) shares are priced at $62.42, giving the company a market cap of 12.13B and a price-to-earnings ratio of 36.92.

Today the stock has traded between $61.29 and $62.97. The current price is 1.8% above the day's low and 0.9% below its high.

Volume so far is 1.11M shares, below the average of 2.12M shares a day.

Over the past year Brightspring Health Services has ranged from $29.01 to $73.75, and now sits 75% of the way up that range.

Brightspring Health Services met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q2 FY26 it reported $0.45 per share against an estimate of $0.4046.

The average analyst price target is $80.55, 29.0% above the current price, from 16 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 16 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 20 analystsAvg $80.55
Low
$70.70
Now
$62.42
High
$94.50

BTSG earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 5 of the last 8 quarters, by 39.9% on average.

  1. Q3 FY24: reported $0.11 per share against an estimate of $0.1775
  2. Q4 FY24: reported $0.22 per share against an estimate of $0.2261
  3. Q1 FY25: reported $0.19 per share against an estimate of $0.0964
  4. Q2 FY25: reported $0.22 per share against an estimate of $0.1742
  5. Q3 FY25: reported $0.39 per share against an estimate of $0.2754
  6. Q4 FY25: reported $0.33 per share against an estimate of $0.357
  7. Q1 FY26: reported $0.39 per share against an estimate of $0.3162
  8. Q2 FY26: reported $0.45 per share against an estimate of $0.4046

BTSG news

  • Chris Katje

    Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

  • Press releasePRNewswire

    BrightSpring Health Services Set to Join S&P MidCap 400 and Karman Holdings to Join S&P SmallCap 600

  • Vandana Singh

    BrightSpring Extends Rally With Solid Q1, Upgraded Fiscal 2026 Forecast

  • Transcript: BrightSpring Health Q1 2026 Earnings Conference Call

  • What to Expect from BrightSpring Health's Earnings

  • Avi Kapoor

    Meta Platforms To $815? Here Are 10 Top Analyst Forecasts For Tuesday

  • Press releasePRNewswire

    BrightSpring Health Services Set to Join S&P SmallCap 600

  • Press releaseGlobe Newswire

    BrightSpring Health Services Announces Onco360® Selected as National Pharmacy Partner for Multiple New Cancer and Rare Disease Drugs

Similar companies

Companies in the same industry as Brightspring Health Services

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.